Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial
Authors: Bonaca MP et al. https://pubmed.ncbi.nlm.nih.gov/29133605 #Secondary Prevention in Peripheral Vascular Disease A. Period of study: The parent FOURIER trial recruited participants from February 2013 to June 2015. Patients were followed for a median of 2.2 years. It was conducted at 1,242 sites across 49 countries. B. Publication date & Journal: Journal: CirculationOnline publication: 13th […]
